Enhanced susceptibility to infections in a diabetic wound healing model
Open Access
- 29 February 2008
- journal article
- Published by Springer Science and Business Media LLC in BMC Surgery
- Vol. 8 (1), 5
- https://doi.org/10.1186/1471-2482-8-5
Abstract
Wound infection is a common complication in diabetic patients. The progressive spread of infections and development of drug-resistant strains underline the need for further insights into bacterial behavior in the host in order to develop new therapeutic strategies. The aim of our study was to develop a large animal model suitable for monitoring the development and effect of bacterial infections in diabetic wounds. Fourteen excisional wounds were created on the dorsum of diabetic and non-diabetic Yorkshire pigs and sealed with polyurethane chambers. Wounds were either inoculated with 2 × 108 Colony-Forming Units (CFU) of Staphylococcus aureus or injected with 0.9% sterile saline. Blood glucose was monitored daily, and wound fluid was collected for bacterial quantification and measurement of glucose concentration. Tissue biopsies for microbiological and histological analysis were performed at days 4, 8, and 12. Wounds were assessed for reepithelialization and wound contraction. Diabetic wounds showed a sustained significant infection (>105 CFU/g tissue) compared to non-diabetic wounds (p < 0.05) over the whole time course of the experiment. S. aureus-inoculated diabetic wounds showed tissue infection with up to 8 × 107 CFU/g wound tissue. Non-diabetic wounds showed high bacterial counts at day 4 followed by a decrease and no apparent infection at day 12. Epidermal healing in S. aureus-inoculated diabetic wounds showed a significant delay compared with non-inoculated diabetic wounds (59% versus 84%; p < 0.05) and were highly significant compared with healing in non-diabetic wounds (97%; p < 0.001). Diabetic wounds developed significantly more sustained infection than non-diabetic wounds. S. aureus inoculation leads to invasive infection and significant wound healing delay and promotes invasive co-infection with endogenous bacteria. This novel wound healing model provides the opportunity to closely assess infections during diabetic wound healing and to monitor the effect of therapeutical agents in vivo.Keywords
This publication has 34 references indexed in Scilit:
- Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threatThe Lancet, 2006
- Systematic review of methods to diagnose infection in foot ulcers in diabetesDiabetic Medicine, 2006
- The molecular biology of chronic wounds and delayed healing in diabetesDiabetic Medicine, 2006
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesThe New England Journal of Medicine, 2005
- Comparison of Tn 1546 -Like Elements in Vancomycin-Resistant Staphylococcus aureus Isolates from Michigan and PennsylvaniaAntimicrobial Agents and Chemotherapy, 2005
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Cutaneous manifestations of diabetes mellitusDermatologic Clinics, 2002
- Activity of Novispirin G10 againstPseudomonas aeruginosaIn Vitro and in Infected BurnsAntimicrobial Agents and Chemotherapy, 2002
- Confocal laser scanning microscopy of porcine skin: implications for human wound healing studiesJournal of Anatomy, 1997
- Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive casesDiabetes Care, 1996